| Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis A Sabo, TR Kress, M Pelizzola, S De Pretis, MM Gorski, A Tesi, MJ Morelli, ... Nature 511 (7510), 488-492, 2014 | 543 | 2014 |
| Integrated systems for NGS data management and analysis: open issues and available solutions V Bianchi, A Ceol, AGE Ogier, S De Pretis, E Galeota, K Kishore, P Bora, ... Frontiers in genetics 7, 75, 2016 | 66 | 2016 |
| A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome K Misselbeck, S Parolo, F Lorenzini, V Savoca, L Leonardelli, P Bora, ... Nature communications 10 (1), 5215, 2019 | 64 | 2019 |
| In search of the right literature search engine (s) A Bajpai, S Davuluri, H Haridas, G Kasliwal, S KS, D Chandrashekar, ... Nature Precedings, 1-1, 2011 | 25 | 2011 |
| Tumorigenesis by Meis1 overexpression is accompanied by a change of DNA target-sequence specificity which allows binding to the AP-1 element L Dardaei, D Penkov, L Mathiasen, P Bora, MJ Morelli, F Blasi Oncotarget 6 (28), 25175, 2015 | 16 | 2015 |
| Comparative evaluation of DNase-seq footprint identification strategies I Barozzi, P Bora, MJ Morelli Frontiers in genetics 5, 278, 2014 | 15 | 2014 |
| A novel tissue-specific meta-analysis approach for gene expression predictions, initiated with a mammalian gene expression testis database KK Acharya, DS Chandrashekar, N Chitturi, H Shah, V Malhotra, S KS, ... BMC genomics 11, 1-10, 2010 | 15 | 2010 |
| Single-cell-led drug repurposing for Alzheimer’s disease S Parolo, F Mariotti, P Bora, L Carboni, E Domenici Scientific Reports 13 (1), 222, 2023 | 14 | 2023 |
| A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersen A Paris, P Bora, S Parolo, D MacCannell, M Monine, N van der Munnik, ... CPT: Pharmacometrics & Systems Pharmacology 12 (2), 196-206, 2023 | 8 | 2023 |
| An age‐dependent mathematical model of neurofilament trafficking in healthy conditions A Paris, P Bora, S Parolo, M Monine, X Tong, S Eraly, E Masson, ... CPT: pharmacometrics & systems pharmacology 11 (4), 447-457, 2022 | 8 | 2022 |
| Computational analysis of cytokine release following bispecific T-cell engager therapy: applications of a logic-based model G Selvaggio, S Parolo, P Bora, L Leonardelli, J Harrold, L Marchetti Frontiers in Oncology 12, 818641, 2022 | 8 | 2022 |
| Reconstruction of the cytokine signaling in lysosomal storage diseases by literature mining and network analysis S Parolo, D Tomasoni, P Bora, A Ramponi, C Kaddi, K Azer, E Domenici, ... Frontiers in Cell and Developmental Biology 9, 703489, 2021 | 6 | 2021 |
| Systems Biology Analysis of Chronic Obstructive Diseases (COPD) Omics Data S Pontis, S Parolo, L Marchetti, A Paris, P Bora, D Tomasoni, E Tantillo, ... C70. COPD (AND LUNG CANCER) CLINICAL AND TRANSLATIONAL STUDIES, A5744-A5744, 2023 | | 2023 |
| AN INTEGRATIVE APPROACH TO IDENTIFY BINDING PARTNERS OF MYC USING (EPI) GENOMICS DATA IN THE 3T9MYCER, EU-MYC AND TET-MYC SYSTEMS P Bora Università degli Studi di Milano, 2017 | | 2017 |
| Abstract A44: Selective transcriptional regulation by Myc in growth control and tumorigenesis A Sabò, TK Kress, M Pelizzola, S Pretis, M Gorski, A Tesi, MJ Morelli, ... Molecular Cancer Therapeutics 13 (10_Supplement), A44-A44, 2015 | | 2015 |
| Corrigendum: Comparative evaluation of DNase-seq footprint identification strategies I Barozzi, P Bora, MJ Morelli Frontiers in Genetics 5, 320, 2014 | | 2014 |
| Journal: Integrated systems for NGS data management and analysis: Open issues and available solutions V Bianchi, A Ceol, AG Ogier, S de Pretis, E Galeota, K Kishore, P Bora, ... | | |
Valerio BianchiWageningen Bioveterinary ResearchVerified email at wur.nl